These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 31347326)
1. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer. Li Y; Sun H; Guan J; Ji T; Wang X Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326 [TBL] [Abstract][Full Text] [Related]
2. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
3. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer. Huang M; He YR; Liang LC; Huang Q; Zhu ZQ World J Gastroenterol; 2017 Sep; 23(34):6330-6338. PubMed ID: 28974900 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer. Hou CG; Luo XY; Li G Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739 [TBL] [Abstract][Full Text] [Related]
5. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer. Lim JB; Chung HW Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618 [TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer. Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607 [TBL] [Abstract][Full Text] [Related]
7. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer. Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325 [TBL] [Abstract][Full Text] [Related]
8. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer. Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960 [TBL] [Abstract][Full Text] [Related]
9. Serum microRNA expression profile as a diagnostic panel for gastric cancer. Huang S; Wang J; Li J; Luo Q; Zhao M; Zheng L; Dong X; Chen C; Che Y; Liu P; Qi J; Huang C Jpn J Clin Oncol; 2016 Sep; 46(9):811-8. PubMed ID: 27380811 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566 [TBL] [Abstract][Full Text] [Related]
11. [Clinical application value of combined detection of serum miR-378 and miR-21 in gastric cancer]. Huang SK; Wang J; Li Y; Lin H; Li DD; Cui CJ; Wang GJ; Li XX; Yang L; Zhao M; Huang CZ Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):441-445. PubMed ID: 29936770 [No Abstract] [Full Text] [Related]
12. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. Song MY; Pan KF; Su HJ; Zhang L; Ma JL; Li JY; Yuasa Y; Kang D; Kim YS; You WC PLoS One; 2012; 7(3):e33608. PubMed ID: 22432036 [TBL] [Abstract][Full Text] [Related]
13. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551 [TBL] [Abstract][Full Text] [Related]
14. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer. Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573 [TBL] [Abstract][Full Text] [Related]
15. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer. Lai H; Jin Q; Lin Y; Mo X; Li B; He K; Chen J Tumour Biol; 2014 Oct; 35(10):10547-54. PubMed ID: 25060181 [TBL] [Abstract][Full Text] [Related]
16. Serum Small Proline-Rich Protein 2A (SPRR2A) Is a Noninvasive Biomarker in Gastric Cancer. Xu X; Wei S; Chen Y; Yu D; Wang X; Dong X Dis Markers; 2020; 2020():8493796. PubMed ID: 32908616 [TBL] [Abstract][Full Text] [Related]
17. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients. Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253 [TBL] [Abstract][Full Text] [Related]
18. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer. Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167 [TBL] [Abstract][Full Text] [Related]
19. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer. Emami SS; Nekouian R; Akbari A; Faraji A; Abbasi V; Agah S J Cancer Res Ther; 2019; 15(1):115-119. PubMed ID: 30880765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]